get a key
steadybase-$ company REGN
account_id none on file
legal_name Regeneron Pharmaceuticals, Inc.
ticker REGN
cik 872589
domain regeneron.com
entry_point_account_id none on file
name Regeneron Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
hq Tarrytown, NY, United States
calls 3 filings 40 executives 6 family 0
why_now
Consistent with what was provided at the J.P. Morgan Conference a few weeks ago, we expect 2026 R&D spend to be in the range of $5.9 to $6.1 billion. The increase versus 2025 is driven by costs to support our expanding late-stage pipeline, including new Phase III studies in oncology and hemat, our Factor XI antibodies, and our obesity program.

Jan 30, 2026 / receipt

calls
Consistent with what was provided at the J.P. Morgan Conference a few weeks ago, we expect 2026 R&D spend to be in the range of $5.9 to $6.1 billion. The increase versus 2025 is driven by costs to support our expanding late-stage pipeline, including new Phase III studies in oncology and hemat, our Factor XI antibodies, and our obesity program.

Jan 30, 2026 / receipt, needs a key / Chris, CFO | earnings call 2026-01-30 | transcript 130db652-0833-4325-8cfa-3a8b8bfbf8f8 | chars 30950-31295 | segment 30

Starting with R&D expense in 2024, which is anticipated to be in the range of $4.3 to $4.5 billion, as George just discussed and as we highlighted at the JPMorgan conference, our pipeline continues to expand with a growing number of registration-enabling studies ongoing, are expected to initiate this year.

Feb 2, 2024 / receipt, needs a key / George Yancopoulos, other | earnings call 2024-02-02 | transcript c17595ca-468d-4dfd-97f1-b4d5cb729ba9 | chars 30973-31280 | segment 31

However, we recently were informed that an FDA travel complication relating to scheduling a routine clinical trial site inspection in Eastern Europe will likely delay their decision until after our September 19th PDUFA date.

Aug 3, 2022 / receipt, needs a key / Bob Landry, CFO | earnings call 2022-08-03 | transcript d2460f26-35af-4e81-9594-2ef6fc22821c | chars 7472-7696 | segment 7

filings
Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Amsterdam3/Director-Market-Access_R50646", "remote": false, "category": "other", "function": "other", "location

company_statement / Sep 16, 2026 / receipt

Director, Regional Market Access Lead - Europe | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Dublin/Director--Regional-Market-Access-Lead---Europe_R50547", "remote": false, "catego

company_statement / Sep 16, 2026 / receipt

Principal Data Engineer | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Limerick/Principal--Data-Engineer_R43097", "remote": false, "category": "other", "function": "data", "location

company_statement / Sep 16, 2026 / receipt

Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Munich/Director-Market-Access_R50648", "remote": false, "category": "other", "function": "other", "location": "

company_statement / Sep 16, 2026 / receipt

Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Paris/Director-Market-Access_R50647", "remote": false, "category": "other", "function": "other", "location": "P

company_statement / Sep 16, 2026 / receipt

Medical Specialist I-Pulmonology-Pittsburgh, PA | {"ats": "workday", "city": "Pittsburgh", "state": "PA", "job_id": "/job/Pittsburgh-PA/Medical-Specialist-I-Pulmonology-Pittsburgh--PA_R50475", "remote

company_statement / Sep 16, 2026 / receipt

Delegado(a) de ventas - Baleares, Barcelona, Gerona y Lerida | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote---Spain/Delegado-a--de-ventas---Baleares--Barcelona--Gerona-y-Leri

company_statement / Sep 16, 2026 / receipt

Scientist, Cardiac Vascular - In Vivo | {"ats": "workday", "city": null, "state": null, "job_id": "/job/TARRYTOWN/Scientist--Cardiac-Vascular---In-Vivo_R49817", "remote": false, "category": "other", "

company_statement / Sep 16, 2026 / receipt

Director Integrated Data Quality | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Warren/Director-Integrated-Data-Quality_R50031", "remote": false, "category": "other", "function": "o

company_statement / Sep 16, 2026 / receipt

Director Market Access | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Dublin/Director-Market-Access_R50435", "remote": false, "category": "other", "function": "other", "location": "

company_statement / Sep 15, 2026 / receipt

Payroll Service Delivery Analyst (International) | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Hyderabad/Payroll-Service-Delivery-Analyst--International-_R50458", "remote": false,

company_statement / Sep 15, 2026 / receipt

Payroll Service Delivery Analyst (US)-1 | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Hyderabad/Payroll-Service-Delivery-Analyst--US--1_R50454", "remote": false, "category": "finan

company_statement / Sep 15, 2026 / receipt

executives
Bob Dean CFO - receipt
Bob Landry CFO - receipt
Christopher Fenimore Senior Vice President - receipt
Dr. George Yancopoulos CSO - receipt
Dr. Leonard Schleifer CEO - receipt
Jason Pitofsky Senior Vice President, Controller - receipt
familynone on file
upcoming
2026-10-30 earnings call scheduled ir
changes
2024-01-31 Senior Vice President, appointed sec_8k
2024-01-31 Vice President, appointed sec_8k
2023-09-08 Executive Vice President, retiring sec_8k
2018-01-02 Executive Vice President, departed sec_8k
mcp_package_hint
steadybase-$